Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Angiopoietin-2 in chronic renal failure patients on hemodialysis: relationship with glomerular filtration rate in the predialysis stages

The Egyptian Journal of Internal Medicine volume 25, pages 225–231 (2013)Cite this article

Abstract

Introduction

Cardiovascular disease has increased as a complication of chronic kidney disease even in the absence of diabetes or hypertension. Angiopoietin-1 and 2 are 55 kDa antagonistic nonredundant gatekeepers of endothelial activation and thus are potential important factors in accelerated atherosclerosis.

Aim of the study

The aim of the study was to determine angiopoietin-2 level in patients on hemodialysis (stage 5) and in the predialytic stages (stages 3 and 4) and to find the relationship between angiopoietin-2 levels and glomerular filtration rate in the predialytic stages.

Patient and methods

We prospectively studied 75 patients divided into three groups and 12 healthy controls. Group 1 included 33 patients on maintenance hemodialysis three times a week; group 2 included 21 patients with stage 3 chronic kidney disease; and group 3 included 21 patients with stage 4 chronic kidney disease.

Results

We found highly significant (P < 0.01) increase in mean serum angiopoietin-2 levels in all three groups compared with the control. The mean angiopoietin-2 in group 1 was 1669.09 ± 472.64 pg/ml, in group 2 was 1206.91 ± 154.26 pg/ml, in group 3 was 1642.24 ± 113.01 pg/ml, and in control was 476.29 ± 150.37 pg/ml. Furthermore, we found highly significant (P < 0.01) increase in group 1 compared with group 2 and group 3, and in group 3 compared with group 2. Our result revealed significant negative correlation of angiopoietin-2 level with estimated glomerular filtration rate in group 2 (r – 0.858, P < 0.01) and group 3 (r – 0.825, P < 0.01), with hemoglobin in group 1 (r – 0.438, P < 0.01), and with BMI (r − 0.468, P < 0.05) and cholesterol (r − 0.503, P<0.05) in group 3; significant positive correlation was observed with uric acid (r 0.456, P < 0.05) in group 3.

Conclusion

Circulating angiopoietin-2 is a putative marker and potential mediator of atherosclerosis, is inversely related to glomerular filtration rate, and is increased with advanced chronic kidney disease. Normolipidemia in chronic kidney disease patients does not prevent atherosclerotic burden; this is because of the presence of other markers such as angiopoietin-2.

References

  1. Lameire N, Jagar K, Van Biesen W. Chronic kidney disease: a European perspective. Kidney Int Suppl 2005; 99: S30–S38.

    Article  Google Scholar 

  2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P. Prevalence of Chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.

    Article  CAS  Google Scholar 

  3. Samak MJ. Cardiovascular complications in CKD. Am J Kidney Dis 2003; 41: 11–17.

    Article  Google Scholar 

  4. David S, Kumpers P, Hellpap J, Horn R, Leitolf H, Hellar H, Kielstein JT. Angiopoietin-2 and CVD in dialysis and kidney transplantation. Am J Kidney Dis 2009; 53: 770–778.

    Article  CAS  Google Scholar 

  5. Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y. Angiopoietin-2 differentially regulates angiogenesis through Tie-2 and integrin signaling. J Clin Invest 2012; 122: 1991–2005.

    Article  CAS  Google Scholar 

  6. Woolf AS, Yuan HT. Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development. Pediatr Nephrol 2001; 16: 177–184.

    Article  CAS  Google Scholar 

  7. David S, John SG, Jefferies HJ, Sigrist MK, Kümpers P, Kielstein JT, Haller H, Christopher W. Angiopoitin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 2012; 27: 1867–1872.

    Article  CAS  Google Scholar 

  8. Shroff RC, Price KL, Kolatsi-joannou M, et al. Circulating Ang-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLoS One 2013; 8: e56273.

    Article  CAS  Google Scholar 

  9. Korff T, Ernst E, Nobiling R, Nobiling R, Feldner A, Reiss Y, Augustin HG, Hecker M. Angio-1 mediates inhibition of hypertension induced release of Angio-2 from endothelial cells. Cardiovasc Res 2012; 94: 510–518.

    Article  CAS  Google Scholar 

  10. National Kidney Foundation. K/DOQI. Guidelines for chronic kidney disease. Evaluation, classification, and stratification. Am J kidney Dis 2002; 39: S1–S266.

    Google Scholar 

  11. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    Article  Google Scholar 

  12. Holopainen T, Saharinen P, D’Amico G. Effects of angiopoietin-2 blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 2012; 104: 461–475.

    Article  CAS  Google Scholar 

  13. Mathew TH, Johnson DW, Jones GR. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007; 187: 459–463.

    Article  Google Scholar 

  14. Twomey PJ, Reynolds TM. The MDRD formula and validation. QJM 2006; 99: 804–805.

    Article  CAS  Google Scholar 

  15. Kallner A, Ayling PA, Khatami Z. Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. Int J Med Sci 2008; 5: 9–17.

    Article  CAS  Google Scholar 

  16. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748–1757.

    Article  CAS  Google Scholar 

  17. Davis S, Papadopoulos N, Aldrich TH, et al. Angiopoietins have distinct molecular domains essential for receptor binding dimerization and super clustering. Nat Struct Biol 2003; 10: 38–44.

    Article  CAS  Google Scholar 

  18. Lieb W, Zachariah JP, Xanthakis V, et al. Clinical and genetic correlates of circulating Ang-2 and soluble Tie-2 in the community. Circ Cardiovasc Genet 2010; 3: 300–306.

    Article  CAS  Google Scholar 

  19. Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468–472.

    Article  CAS  Google Scholar 

  20. Chang FC, Lai TS, Chiang CK, et al. Ang-2 is associated with albuminuria & micro-inflammation in CKD. PLoS One 2013; 8: e54668.

    Article  CAS  Google Scholar 

  21. David S, Kűmmpers P, Lukasz A, et al. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2571–2579.

    Article  CAS  Google Scholar 

  22. Kumpers P, Hafer C, David S, et al. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010; 36: 462–470.

    Article  CAS  Google Scholar 

  23. Kumpers P, Hellpap J, David S, Horn R, Leitolf H, haller H, Haubitz M. Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement. Nephrol Dial Transplant 2009; 1845–1850.

  24. Kuo MC, Patschan D, Goligorsky MS. Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells. J Am Soc Nephrol 2008; 19: 2321–2330.

    Article  CAS  Google Scholar 

  25. Yu MA, Sanchez-lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010; 28: 1234–1242.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Abbasia, Cairo, Egypt

    Fatma A. Attia MD

  2. Department of Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt

    Nagwa A. Mohammed & Al-Shymaa A. Ibrahim

Authors
  1. Fatma A. Attia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nagwa A. Mohammed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Al-Shymaa A. Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatma A. Attia MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Attia, F.A., Mohammed, N.A. & Ibrahim, AS.A. Angiopoietin-2 in chronic renal failure patients on hemodialysis: relationship with glomerular filtration rate in the predialysis stages. Egypt J Intern Med 25, 225–231 (2013). https://doi.org/10.4103/1110-7782.125003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-7782.125003

Keywords